Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

Latest in Blood
Plenary Papers
Ada Antypiuk; S. Zebulon Vance; Richa Sharma; Sara Passos; Michela Asperti; Shobana Navaneethabalakrishan; Franz Dürrenberger; Vania Manolova; Francesca Vinchi
First Edition
Fangwu Wang; Laura Gonzalez; Qiuyu Lian; Colin A Hammond; Yasmine Y.M. Lau; Benjamin D. Simons; Martin Hirst; Connie J Eaves
Clinical Trials and Observations
Ioannis Mantzaris; Mendel Goldfinger; Matan Uriel; Aditi Shastri; Nishi Shah; Kira Gritsman; Noah S. Kornblum; Lauren Shapiro; Roberto Alejandro Sica; Anne Munoz; Nicole Chambers; Aradhika Dhawan; Jhannine Alyssa Verceles; Karen Fehn; Balda Tirone; Lamisha Shah; Shaunmonique Clark; Chenxin Zhang; Mimi Kim; Dennis L. Cooper; Amit Verma; Marina Konopleva; Eric J. Feldman

Advertisement intended for health care professionals


170,000 citations
earned in 2023



Featured Content

The decline of transplant for relapsed myeloma; DDAVP response in bleeding disorders; dual DOT1L/EZH2 targeting in DLBCL

Salvage autologous transplant in relapsed multiple myeloma: long-term follow-up of the phase 3 GMMG ReLApsE trial

DDAVP response and its determinants in bleeding disorders: a systematic review and meta-analysis

Targeting DOT1L and EZH2 synergizes in breaking the germinal center identity of diffuse large B-cell lymphoma

HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+ lymphoma

How I Treat Series: Myeloproliferative Neoplasms

Close Modal

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals